iga

FDA makes low-risk determination for marketing of products from genome-edited beef cattle

On March 7, the U.S. Food and Drug Administration in a news release announced it has made a low-risk determination for the marketing of products, including food, from two genome-edited beef cattle and their offspring after determining that the intentional genomic alteration do... Read More